FR Doc E8-14590[Federal Register: June 27, 2008 (Volume 73,
Number 125)] [Notices] [Page 36572] From the Federal Register
Online via GPO Access [wais.access.gpo.gov] [DOCID:fr27jn08-93]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances Notice of Application
Pursuant to 21
U.S.C. 958(i), the Attorney General shall, prior to issuing
a registration under this Section to a bulk manufacturer of a
controlled substance in schedule I or II, and prior to issuing a
registration under 21
U.S.C. 952(a)(2) authorizing the importation of such a
substance, provide manufacturers holding registrations for the
bulk manufacture of the substance an opportunity for a hearing.
Therefore, in accordance with Title 21 Code of Federal
Regulations (CFR), 1301.34(a), this is notice that on May 8,
2008, Aptuit, 10245 Hickman Mills Drive, Kansas City, Missouri
64137, made application by renewal to the Drug Enforcement
Administration (DEA) to be registered as an importer of
Marihuana (7360), a basic class of controlled substance listed
in schedule I.
The company plans to import a finished pharmaceutical product
containing cannabis extracts in dosage form for packaging for a
clinical trial study.
Any bulk manufacturer who is presently, or is applying to be,
registered with DEA to manufacture such basic class of
controlled substance may file comments or objections to the
issuance of the proposed registration and may, at the same time,
file a written request for a hearing on such application
pursuant to 21
CFR 1301.43 and in such form as prescribed by 21
CFR 1316.47.
Any such comments or objections being sent via regular mail
should be addressed, in quintuplicate, to the Drug Enforcement
Administration, Office of Diversion Control, Federal Register
Representative (ODL), Washington, DC 20537, or any being sent
via express mail should be sent to Drug Enforcement
Administration, Office of Diversion Control, Federal Register
Representative (ODL), 8701 Morrissette Drive, Springfield, VA
22152; and must be filed no later than July 28, 2008.
This procedure is to be conducted simultaneously with, and
independent of, the procedures described in 21
CFR 1301.34(b), (c), (d), (e), and (f). As noted in a
previous notice published in the Federal Register on September
23, 1975, (40 FR 43745-46), all applicants for registration to
import a basic class of any controlled substance in schedule I
or II are, and will continue to be, required to demonstrate to
the Deputy Assistant Administrator, Office of Diversion Control,
Drug Enforcement Administration, that the requirements for such
registration pursuant to 21 U.S.C. 958(a); 21
U.S.C. 823(a); and 21 CFR 1301.34(b), (c), (d), (e), and (f)
are satisfied.
Dated: June 19, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion
Control, Drug Enforcement Administration.
[FR Doc. E8-14590 Filed 6-26-08; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).